Effects of Dietary Nitrate in Women With Secondary Amenorrhea
1 other identifier
interventional
12
1 country
1
Brief Summary
Excessive exercise, disordered attitudes toward eating, physical and psychological stress, and/or hormonal imbalances may result in cessation of menstruation (secondary amenorrhea). The accompanying lack of estrogen may impair muscle power and oxygen recovery after exercise by reducing nitric oxide levels. The purpose of this study is to determine whether ingestion of beetroot juice containing nitrate, an alternative source of nitric oxide, can help reverse these changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2025
CompletedFirst Posted
Study publicly available on registry
June 13, 2025
CompletedStudy Start
First participant enrolled
September 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedSeptember 24, 2025
September 1, 2025
8 months
June 5, 2025
September 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Maximal knee extensor power
Maximal power of the knee extensor (thigh) muscles as determined using isokinetic dynamometry
Approximately 2-3 hours after beetroot ingestion
Muscle reoxygenation kinetics
Recovery rate constant (k) of muscle oxygenation following exercise as determined using NIRS (near-infrared spectroscopy) combined with brief intermittent arterial occlusion
Approximately 2-3 hours after beetroot juice ingestion
Secondary Outcomes (3)
Maximal knee extensor velocity
Approximately 2-3 hours after beetroot juice ingestion
Deoxygenation rate
Approximately 2-3 hours after beetroot juice ingestion
Reoxygenation rate
Approximately 2-3 hours after beetroot juice ingestion
Other Outcomes (6)
Baseline plasma nitrate/nitrite concentration
Before beetroot juice ingestion
Plasma nitrate/nitrite concentration at 1 hour
1 hour after beetroot juice ingestion
Plasma nitrate/nitrite concentration at 2 hours
2 hours after beetroot juice ingestion
- +3 more other outcomes
Study Arms (2)
Placebo
PLACEBO COMPARATORNitrate-free beetroot juice
Nitrate
EXPERIMENTALNitrate-rich beetroot juice
Interventions
Eligibility Criteria
You may qualify if:
- Women age 18-44 years old
- Missed \>3 consecutive periods in the last 12 months if previously regularly menstruating (average cycle 21-35 d) OR
- Missed \>6 consecutive periods in the last 12 month if previously irregularly menstruating (spontaneous menstruation, average cycle \<21 or \> 35 d)
You may not qualify if:
- Unable to provide informed consent
- Currently diagnosed with primary amenorrhea (no history of menstruation by age 15) or oligomenorrhea (menstrual cycle \>35 d or \<8 cycles per year)
- Currently diagnosed with a chronic illness, including thyroid disease, hyperprolactinemia, Cushing syndrome, and/or poly-cystic ovarian syndrome (PCOS)
- History or current clinical diagnosis of an eating disorder
- Currently dieting
- Weight instablility for the past 3 months
- Previously undergone a revascularization procedure involving a vascular graft or stenting of the femoral or popliteal arteries
- Currently at the time of screening, or in the past year, using hormonal contraceptives
- Pregnancy
- Epilepsy
- Current antibiotic use
- Current nicotine user
- Stage II hypertension (resting blood pressure \>140/\>90)
- Currently taking proton pump inhibitors, antacids, xanthine oxidase inhibitors, or on hormone replacement therapy
- If participant's doctor has ever said that he/she has a heart condition and that he/she should only do physical activity recommended by a doctor
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University Indianapolis
Indianapolis, Indiana, 46202, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew R Coggan, PhD
Indiana University Indianapolis
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 5, 2025
First Posted
June 13, 2025
Study Start
September 5, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
September 24, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be made available upon completion of the study and publication of the final results.
All non-PHI individual participant data will be shared upon reasonable request.